Overview
- Neogen posted adjusted EPS of $0.10 and revenue of about $224.7 million, beating consensus estimates.
- The company raised fiscal 2026 sales guidance to $845–$855 million and now targets about $175 million in Adjusted EBITDA.
- Shares rose roughly 28% to 34% intraday Thursday following the report and outlook upgrade.
- The quarterly net loss narrowed to $15.9 million from $456.3 million in the prior-year period, with core revenue growth of 2.9%.
- CEO Mike Nassif said the first phase of a strategic transformation is underway as the company benefits from heightened food-contamination concerns and regulatory changes.